Pathogenesis of Primary Biliary Cirrhosis

由 Jones, David E J
出版 2007

Addisons' other disease: primary biliary cirrhosis as a model autoimmune disease

由 Jones, David E J
發表在 Clin Med (Lond) (2003)

Handbook of petroleum processing

由 Jones, David S. J., Pujadó, Peter R.
出版 2006

Authors' reply

由 Jones, David E J, Newton, Julia L
出版 2007

Toll-like receptor interactions: tolerance of MyD88-dependent cytokines but enhancement of MyD88-independent interferon-β production

由 Broad, Andrea, Kirby, John A, Jones, David E J
出版 2007

Novel bile acid therapeutics for the treatment of chronic liver diseases

由 Hegade, Vinod S., Speight, R. Alexander, Etherington, Rachel E., Jones, David E. J.
發表在 Therap Adv Gastroenterol (2016)

Impaired cardiovascular function in primary biliary cirrhosis

由 Jones, David E. J., Hollingsworth, Kieren, Fattakhova, Gulnar, MacGowan, Guy, Taylor, Roy, Blamire, Andrew, Newton, Julia L.
出版 2010

Bile acid receptor agonists in primary biliary cholangitis: Regulation of the cholangiocyte secretome and downstream T cell differentiation

由 Etherington, Rachel E., Millar, Benjamin J. M., Innes, Barbara A., Jones, David E. J., Kirby, John A., Brain, John G.
發表在 FASEB Bioadv (2019)

Position statement on access to care in rare liver diseases: advancements of the European reference network (ERN) RARE-LIVER

由 Bernts, Lucas H. P., Jones, David E. J., Kaatee, Marleen M., Lohse, Ansgar W., Schramm, Christoph, Sturm, Ekkehard, Drenth, Joost P. H.
發表在 Orphanet J Rare Dis (2019)

Cardiac torsion-strain relationships in fatigued primary biliary cirrhosis patients show accelerated aging: a pilot cross-sectional study

由 Hollingsworth, Kieren G., MacGowan, Guy A., Morris, Louise, Bates, Matthew G. D., Taylor, Roy, Jones, David E. J., Newton, Julia L., Blamire, Andrew M.
出版 2012

Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom

由 Dyson, Jessica K., Wong, Lin Lee, Bigirumurame, Theophile, Hirschfield, Gideon M., Kendrick, Stuart, Oo, Ye H., Lohse, Ansgar W, Heneghan, Michael A., Jones, David E. J.
發表在 Aliment Pharmacol Ther (2018)

Changing Nomenclature for PBC: From ‘Cirrhosis' to ‘Cholangitis'

由 Beuers, Ulrich, Gershwin, M Eric, Gish, Robert G, Invernizzi, Pietro, Jones, David E J, Lindor, Keith, Ma, Xiong, Mackay, Ian R, Parés, Albert, Tanaka, Atsushi, Vierling, John M, Poupon, Raoul
發表在 Am J Gastroenterol (2015)

The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility

由 Wong, Lin Lee, Fisher, Holly F, Stocken, Deborah D, Rice, Stephen, Khanna, Amardeep, Heneghan, Michael A, Oo, Ye Htun, Mells, George, Kendrick, Stuart, Dyson, Jessica Katharine, Jones, David E. J.
發表在 Hepatology (2018)

BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial

由 Hegade, Vinod S., Kendrick, Stuart F. W., Dobbins, Robert L., Miller, Sam R., Richards, Duncan, Storey, James, Dukes, George, Gilchrist, Kim, Vallow, Susan, Alexander, Graeme J., Corrigan, Margaret, Hirschfield, Gideon M., Jones, David E. J.
發表在 BMC Gastroenterol (2016)

The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines

由 Hirschfield, Gideon M, Dyson, Jessica K, Alexander, Graeme J M, Chapman, Michael H, Collier, Jane, Hübscher, Stefan, Patanwala, Imran, Pereira, Stephen P, Thain, Collette, Thorburn, Douglas, Tiniakos, Dina, Walmsley, Martine, Webster, George, Jones, David E J
發表在 Gut (2018)

The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort

由 Pells, Greta, Mells, George F., Carbone, Marco, Newton, Julia L., Bathgate, Andrew J., Burroughs, Andrew K., Heneghan, Michael A., Neuberger, James M., Day, Darren B., Ducker, Samantha J., Sandford, Richard N., Alexander, Graeme J., Jones, David E.J.
發表在 J Hepatol (2013)

αEβ7 Integrin Identifies Subsets of Pro-Inflammatory Colonic CD4+ T Lymphocytes in Ulcerative Colitis

由 Lamb, Christopher A., Mansfield, John C., Tew, Gaik W., Gibbons, Deena, Long, Anna K., Irving, Peter, Diehl, Lauri, Eastham-Anderson, Jeff, Price, Maria B., O’Boyle, Graeme, Jones, David E. J., O’Byrne, Sharon, Hayday, Adrian, Keir, Mary E., Egen, Jackson G., Kirby, John A.
發表在 J Crohns Colitis (2017)

The UK-PBC Risk Scores: Derivation and Validation of a Scoring System for Long-Term Prediction of End-Stage Liver Disease in Primary Biliary Cholangitis

由 Carbone, Marco, Sharp, Stephen J., Flack, Steve, Paximadas, Dimitrios, Spiess, Kelly, Adgey, Carolyn, Griffiths, Laura, Lim, Reyna, Trembling, Paul, Williamson, Kate, Wareham, Nick J., Aldersley, Mark, Bathgate, Andrew, Burroughs, Andrew K., Heneghan, Michael A., Neuberger, James M., Thorburn, Douglas, Hirschfield, Gideon M., Cordell, Heather J., Alexander, Graeme J., Jones, David E.J., Sandford, Richard N., Mells, George F.
發表在 Hepatology (2016)

TGF-β2 silencing to target biliary-derived liver diseases

由 Dropmann, Anne, Dooley, Steven, Dewidar, Bedair, Hammad, Seddik, Dediulia, Tatjana, Werle, Julia, Hartwig, Vanessa, Ghafoory, Shahrouz, Woelfl, Stefan, Korhonen, Hanna, Janicot, Michel, Wosikowski, Katja, Itzel, Timo, Teufel, Andreas, Schuppan, Detlef, Stojanovic, Ana, Cerwenka, Adelheid, Nittka, Stefanie, Piiper, Albrecht, Gaiser, Timo, Beraza, Naiara, Milkiewicz, Malgorzata, Milkiewicz, Piotr, Brain, John G, Jones, David E J, Weiss, Thomas S, Zanger, Ulrich M, Ebert, Matthias, Meindl-Beinker, Nadja M
發表在 Gut (2020)